PKPH
$2.00
Peak Pharmaceuticals
($.55)
(21.57%)
PKPH
Earnings Whisper ®
N/A
Consensus:  $0.00
Revenue:  N/A
Monday
Apr 3
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when PKPH reports earnings?
Beat
Meet
Miss

Where is PKPH's stock price going from here?
Up
Flat
Down
Stock chart of PKPH
Analysts
Summary of analysts' recommendations for PKPH
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Peak Pharmaceuticals, Inc. is involved in the development, manufacturing, sales and marketing of pharmaceutical-grade, hemp-based nutraceutical and supplement products for the human and animal health markets. Peak Pharmaceuticals, Inc., formerly known as Cannabis Therapy Corp, is based in Aurora, Colorado.
Peers
Regeneron PharmaceuticalsBioMarin PharmaceuticalBristol-Myers SquibbJohnson & JohnsonEli LillyVertex PharmaceuticalsMerck & Co.PfizerArray TechnologiesUltragenyx Pharmaceutical